Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
| Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. | Clin Immunol | 2023 | 37150240 | PubTator, text mining | PubMed |
| SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123398 | PubTator, text mining | PubMed |
| Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer. | Clin Transl Oncol | 2023 | 37095423 | PubTator, text mining | PubMed |
| Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma. | Front Med (Lausanne) | 2023 | 37081847 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer. | Front Oncol | 2023 | 37064084 | PubTator, text mining | PubMed |
| Pan-cancer landscape of CENPO and its underlying mechanism in LUAD. | Respir Res | 2023 | 37061713 | PubTator, text mining | PubMed |
| Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. | Cell Death Discov | 2023 | 37059713 | PubTator, text mining | PubMed |
| Integrated systems immunology approach identifies impaired effector T cell memory responses as a feature of progression to severe dengue fever. | J Biomed Sci | 2023 | 37055751 | PubTator, text mining | PubMed |
| Screening ANLN and ASPM as bladder urothelial carcinoma-related biomarkers based on weighted gene co-expression network analysis. | Front Genet | 2023 | 37051591 | PubTator, text mining | PubMed |
| Association analysis of hepatocellular carcinoma-related hub proteins and hub genes. | Proteomics Clin Appl | 2023 | 37050894 | PubTator, text mining | PubMed |
| Immuno-Stimulating Activity of 1,25-Dihydroxyvitamin D in Blood Cells from Five Healthy People and in Blasts from Five Patients with Leukemias and Pre-Leukemic States. | Int J Mol Sci | 2023 | 37047477 | PubTator, text mining | PubMed |
| Roles of p53-Mediated Host-Virus Interaction in Coronavirus Infection. | Int J Mol Sci | 2023 | 37047343 | PubTator, text mining | PubMed |
| Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients. | Comput Biol Med | 2023 | 37040675 | PubTator, text mining | PubMed |
| Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape. | Nat Methods | 2023 | 37038000 | PubTator, text mining | PubMed |
| Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma. | Genes Dev | 2023 | 37024284 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer. | Front Genet | 2023 | 37007961 | PubTator, text mining | PubMed |
| Cinnamomi ramulus inhibits cancer cells growth by inducing G2/M arrest. | Front Pharmacol | 2023 | 37007025 | PubTator, text mining | PubMed |
| High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis. | Front Genet | 2023 | 36999057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=16